Abstract: Provided is a method for interaction of multi-party medical information, a computer device and a storage medium. The method includes: displaying medical statistical data of a target user in a pre-established multi-party consultation group for the target user, wherein the multi-party consultation group includes members of a plurality of medical disciplines associated with the target user and a virtual object; acquiring medical opinions for the target user fed back by the members in the multi-party consultation group; and determining, based on the medical opinions, a medical consultation conclusion for the target user.

Abstract: The present disclosure relates to a new use of anlotinib, and relates in particular to anlotinib inhibiting osteosarcoma and chondrosarcoma growth and metastasis. It has been discovered for the first time that anlotinib can inhibit osteosarcoma and chondrosarcoma growth and metastasis. Anlotinib can significantly inhibit the growth of the osteosarcoma cell lines 143B, U2OS, MG63 and SJSA, induce cycle arrest in said cell lines, and can also inhibit osteosarcoma cell line migration and invasion. It has also been discovered for the first time that anlotinib can enhance the killing effect of the chemotherapeutic drug cisplatin on osteosarcoma cells.